China’s Tech IPOs Weigh Hong Kong vs the Mainland — But How Much Does the Choice Really Matter?

For Chinese technology companies preparing to go public, one of the first strategic questions is also one of the oldest: list at home, or list in Hong Kong?

It is a decision that has traditionally carried enormous weight. Mainland exchanges in Shanghai and Shenzhen, including the science-and-technology focused STAR Market and the growth-oriented ChiNext board, offer access to a deep pool of domestic savings and investors who often assign generous valuations to companies with recognisable consumer brands or strategic technologies. Hong Kong, by contrast, offers convertible currency, fewer capital controls and a gateway to global institutional money — along with the scrutiny and valuation discipline that comes with it.

Yet as the two markets have grown more intertwined, the practical gap between them has narrowed in ways that complicate the old calculus.

Two markets, converging

Hong Kong’s appeal has long rested on its role as the bridge between Chinese issuers and international capital. Reforms in recent years opened the door to companies with weighted voting rights and to pre-revenue biotech and specialist technology firms, narrowing one of the mainland’s advantages for loss-making but fast-growing businesses.

Mainland exchanges, meanwhile, have moved in the opposite direction, loosening profitability requirements for certain technology listings and streamlining registration-based approval processes. The result is that many companies now find themselves genuinely eligible for both venues rather than being funnelled toward one by regulation alone.

The Stock Connect schemes linking Hong Kong with Shanghai and Shenzhen have further blurred the line. Mainland investors can buy qualifying Hong Kong-listed shares, and international investors can access mainland-listed stocks, meaning the identity of a company’s shareholder base is no longer determined purely by where its shares happen to trade.

Why the choice still has consequences

None of this makes the decision trivial. Valuation dynamics still diverge: domestic retail enthusiasm can support higher multiples on mainland boards, particularly in sectors tied to national priorities such as semiconductors, artificial intelligence and advanced manufacturing. Hong Kong listings, priced against global comparables, can look cheaper on paper but offer easier follow-on fundraising in US dollars and a clearer path for companies with overseas expansion plans.

Liquidity, index inclusion, lock-up conventions, disclosure obligations and the ease with which early venture backers can exit all differ between the two. For firms with foreign shareholders or offshore holding structures, Hong Kong often remains the simpler technical route. For those whose customers, suppliers and revenues are overwhelmingly domestic, the mainland may be the more natural home.

There is also a growing pattern of companies refusing to choose at all. Dual listings — a mainland base paired with a Hong Kong offering, or the reverse — have become a familiar route for larger issuers seeking both domestic recognition and international reach.

The bigger variable

Ultimately, bankers and founders alike tend to concede that market conditions matter more than venue. A strong business launching into a receptive market will usually find buyers on either side of the border; a weak one will struggle in both. Investor appetite for Chinese technology risk, the interest-rate environment, and the pace of regulatory approvals shape outcomes far more decisively than the exchange logo on a listing document.

The Hong Kong–versus–mainland debate remains a real one, with real trade-offs around currency, shareholder base and valuation. But for a growing number of Chinese tech companies, it is becoming less a fork in the road than a question of sequencing — which market first, and how soon the other follows. Read More